5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
暂无分享,去创建一个
Daniela Prayer | Georg Widhalm | Barbara Kiesel | Engelbert Knosp | Stefan Wolfsberger | Adelheid Woehrer | Matthias Preusser | Johannes A. Hainfellner | C. Marosi | D. Prayer | J. Hainfellner | M. Preusser | E. Knosp | A. Woehrer | B. Kiesel | T. Traub-Weidinger | S. Wolfsberger | G. Widhalm | Christine Marosi | Tatjana Traub-Weidinger
[1] R Grant,et al. Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force , 2010, European journal of neurology.
[2] Frederic Leblond,et al. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence in Meningioma: Qualitative and Quantitative Measurements In Vivo , 2014, Neurosurgery.
[3] K. Fujii,et al. Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. , 2006, Journal of neurosurgery.
[4] W. Stummer,et al. Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.
[5] Susan M. Chang,et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Xiaoyao Fan,et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.
[7] Christopher Nimsky,et al. Brain shift compensation and neurosurgical image fusion using intraoperative MRI: current status and future challenges. , 2012, Critical reviews in biomedical engineering.
[8] G. Reifenberger,et al. 5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study , 2012, Acta Neurochirurgica.
[9] Eljamel Ms. Which intracranial lesions would be suitable for 5-aminolevulenic acid-induced fluorescence-guided identification, localization, or resection? A prospective study of 114 consecutive intracranial lesions. , 2009 .
[10] Christopher Nimsky,et al. Updating Navigation With Intraoperative Image Data , 2008, Topics in magnetic resonance imaging : TMRI.
[11] R. Mirimanoff,et al. Prognostic factors for low-grade gliomas. , 2003, Seminars in oncology.
[12] H. Haro,et al. Report of 2 cases , 2008 .
[13] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[14] Keith D. Paulsen,et al. δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. , 2011, Neuro-oncology.
[15] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[16] Boguslaw Tomanek,et al. Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies , 2012, Neurosurgical Review.
[17] I. Yang. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas , 2012 .
[18] W. Stummer,et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.
[19] Michael Sabel,et al. Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[20] D. Prayer,et al. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. , 2007, Minimally invasive neurosurgery : MIN.
[21] Keith D. Paulsen,et al. Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas. , 2011, Neurosurgical focus.
[22] J. Saver,et al. A Quantitative Study , 2005 .
[23] Kimito Yamada,et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. , 2011, Journal of neurosurgery.
[24] D. Prayer,et al. 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement , 2010, Cancer.
[25] E. B. Jackson,et al. Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors , 1940 .
[26] M. Eljamel. Which intracranial lesions would be suitable for 5-aminolevulenic acid-induced fluorescence-guided identification, localization, or resection? A prospective study of 114 consecutive intracranial lesions. , 2009, Clinical neurosurgery.
[27] Xiaoyao Fan,et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.
[28] Hugues Duffau,et al. Surgery of low-grade gliomas: towards a ‘functional neurooncology’ , 2009, Current opinion in oncology.
[29] M Schwaiger,et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] J. Fandino,et al. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas , 2010, Acta Neurochirurgica.
[31] M. Matsumae,et al. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. , 2011, World neurosurgery.
[32] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[33] Xiaofeng Chen,et al. Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid–Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies , 2013, PloS one.
[34] R. Stupp,et al. Current concepts and management of glioblastoma , 2011, Annals of neurology.
[35] F. Floeth,et al. Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence , 2011, Clinical Neurology and Neurosurgery.
[36] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[37] H. Kishima,et al. 11C‐methionine uptake and intraoperative 5‐aminolevulinic acid‐induced fluorescence as separate index markers of cell density in glioma , 2012, Cancer.
[38] Kaoru Sakatani,et al. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. , 2007, Neurologia medico-chirurgica.
[39] Zhen Cheng,et al. Image-guided resection of malignant gliomas using fluorescent nanoparticles. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[40] A. von Deimling,et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. , 2011, Neuro-oncology.
[41] M. Hefti,et al. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies , 2012, Acta Neurochirurgica.
[42] R. Tsien,et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.
[43] Roberto Rey-Dios,et al. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. , 2014, World neurosurgery.
[44] G von Campe,et al. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.
[45] Sachio Suzuki,et al. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study , 2007, Brain Tumor Pathology.
[46] Michael Weller,et al. Changing paradigms--an update on the multidisciplinary management of malignant glioma. , 2006, The oncologist.
[47] W. Paulus,et al. Intratumoral histologic heterogeneity of gliomas. A quantitative study , 1989, Cancer.
[48] C. Nimsky,et al. Quantification of, Visualization of, and Compensation for Brain Shift Using Intraoperative Magnetic Resonance Imaging , 2000, Neurosurgery.
[49] Thomas Czech,et al. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[50] R. Tsien,et al. Fluorescence-guided surgery with live molecular navigation — a new cutting edge , 2013, Nature Reviews Cancer.
[51] C. Marosi,et al. [11C] Methionine and [18F] Fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme , 2007, Journal of Neuro-Oncology.